Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES TAKEDA SUBSIDIARY LISTING<br />
Prin ci pal Prod ucts:<br />
BLOPRESS (an gio ten sin-II an tag o nist plain)<br />
TAKEPRON (antiulcerant)<br />
LEUPLIN (cytostatic hor mone; hor mone hy po tha -<br />
lamic)<br />
BASEN (antidiabetic oral)<br />
ACTOS (antidiabetic oral)<br />
Ther a peu tic Range:<br />
renin-an gio ten sin sys tem agents 27%<br />
drugs used in di a be tes 20%<br />
ant ac ids/antiflatulents/antiulcerants 14%<br />
cytostatic hor mone ther apy 12%<br />
vi ta mins 5%<br />
Lead ing Dose Forms:<br />
tab lets 63%<br />
pre-filled sy ringes/pens 13%<br />
coated tab lets 10%<br />
vi als 6%<br />
cap sules 3%<br />
WAKO PURE CHEM I CAL IN DUS TRIES<br />
Full Name: Wako Pure Chem i cal In dus tries, Ltd.<br />
Street Ad dress: 1-2, Doshomachi 3-chome<br />
Chuo-ku, Osaka 541-0045<br />
Tel: +81 6 6203 3741<br />
Fax: +81 6 6203 2029<br />
Home Page: www.takeda.co.jp<br />
De scrip tion: Pre vi ously known as Takeda To kyo.<br />
Sub sid iary of: Takeda, Ja pan (70.3%)<br />
� NETHERLANDS<br />
TAKEDA<br />
Full Name: Takeda Eu rope Hold ings B.V.<br />
Street Ad dress: WTC Am ster dam A-12,<br />
Strawinskylaan 1217, 1077 XX Am ster dam<br />
De scrip tion: Hold ing com pany.<br />
Par ent of: Takeda, France (100%); Takeda<br />
Pharma, Ger many (100%); Takeda, It aly<br />
(76.92%); Takeda, UK (100%); Takeda Cam -<br />
bridge, UK (100%); Takeda Global R&D, UK<br />
(100%); Takeda Pharma, UK (100%).<br />
Sub sid iary of: Takeda, Ja pan (100%)<br />
� PHILIPPINES<br />
BOIE-TAKEDA<br />
Full Name: Boie-Takeda Chem i cals Inc<br />
Street Ad dress: 12/F, Sky Plaza Bldg., 6788<br />
Ayala Av e nue, Oledan Square, Makati City<br />
Tel: +63 2 886-69-54/61<br />
Fax: +63 2 886-69-41<br />
Email: takeda@boie-takeda.com<br />
De scrip tion: De vel oper, dis trib u tor. Prod uct<br />
ranges in clude: phar ma ceu ti cal prod ucts<br />
(branded, pre scrip tion), oph thal mic prod ucts. Es -<br />
tab lished 1968. 135 phar ma ceu ti cal employees in<br />
2007.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 85 (2007)<br />
Con tacts (Pharm): Chair man: Nick A. Lansang;<br />
Com mer cial Op er a tions: Ed Kanap(Sales), Edwin<br />
Villavieva (Mar ket ing); Re search & De vel op ment:<br />
Asuncion Sayson; Gen eral Con tact: Chris tine<br />
Abonguey<br />
Sub sid iary of: Boie, Phil ip pines (50%); Takeda,<br />
Ja pan (50%) (group: Takeda, Ja pan)<br />
Phar ma ceu ti cal Sales: US$ 12-14 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 75-80%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 90-95%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
PREVACID (antiulcerant)<br />
BLOPRESS (an gio ten sin-II an tag o nist plain)<br />
ACTOS (antidiabetic oral)<br />
BLOPRESS PLUS (an gio ten sin-II an tag o nist com -<br />
bi na tion)<br />
LUPROLEX (cytostatic hor mone)<br />
Ther a peu tic Range:<br />
renin-an gio ten sin sys tem agents 31%<br />
ant ac ids/antiflatulents/antiulcerants 25%<br />
drugs used in di a be tes 19%<br />
cytostatic hor mone ther apy 11%<br />
vi ta mins 6%<br />
Lead ing Dose Forms:<br />
tab lets 71%<br />
vi als 11%<br />
cap sules 7%<br />
coated tab lets 6%<br />
am poules 4%<br />
� SINGAPORE<br />
GREEN CROSS<br />
Full Name: Green Cross Pharma Pte Ltd<br />
Street Ad dress: 63 Hillview Ave, 08-18 Lam<br />
Soon In dus trial Bldg, Sin ga pore 669569<br />
Tel: +65 6 7630388<br />
Fax: +65 6 7634676<br />
Email: sales@greencross.com.sg<br />
De scrip tion: Im porter, ex porter, dis trib u tor,<br />
pro moter, sales/detailer. Im ports, ex ports, dis -<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 127
Change language